title: RACK-1 overexpression protects against goniothalamin-induced cell death.
abstract: Goniothalamin, a styryllactone, has been shown to induce cytotoxicity via apoptosis in several tumor cell lines. In this study, we have examined the potential role of several genes, which were stably transfected into T-cell lines and which regulate apoptosis in different ways, on goniothalamin-induced cell death. Overexpression of full-length receptor for activated protein C-kinase 1 (RACK-1) and pc3n3, which up-regulates endogenous RACK-1, in both Jurkat and W7.2 T cells resulted in inhibition of goniothalamin-induced cell death as assessed by MTT and clonogenic assays. However, overexpression of rFau (antisense sequence to Finkel-Biskis-Reilly murine sarcoma virus-associated ubiquitously expressed gene) in W7.2 cells did not confer resistance to goniothalamin-induced cell death. Etoposide, a clinically used cytotoxic agent, was equipotent in causing cytotoxicity in all the stable transfectants. Assessment of DNA damage by Comet assay revealed goniothalamin-induced DNA strand breaks as early as 1 h in vector control but this effect was inhibited in RACK-1 and pc3n3 stably transfected W7.2 cells. This data demonstrate that RACK-1 plays a crucial role in regulating cell death signalling pathways induced by goniothalamin.
authors.affiliation: Toxicology and Biocompatibility Laboratory, Faculty of Allied Health Sciences, Universiti Kebangsaan Malaysia. salmaan@medic.ukm.my
authors.forename: S H
authors.initials: SH
authors.lastname: Inayat-Hussain
authors.forename: L T
authors.initials: LT
authors.lastname: Wong
authors.forename: K M
authors.initials: KM
authors.lastname: Chan
authors.forename: N F
authors.initials: NF
authors.lastname: Rajab
authors.forename: L B
authors.initials: LB
authors.lastname: Din
authors.forename: R
authors.initials: R
authors.lastname: Harun
authors.forename: A
authors.initials: A
authors.lastname: Kizilors
authors.forename: N
authors.initials: N
authors.lastname: Saxena
authors.forename: M
authors.initials: M
authors.lastname: Mourtada-Maarabouni
authors.forename: F
authors.initials: F
authors.lastname: Farzaneh
authors.forename: G T
authors.initials: GT
authors.lastname: Williams
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D016923:Cell Death / Q000187:drug effects; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002999:Clone Cells; D003114:Colony-Forming Units Assay; D004396:Coloring Agents; D020552:Comet Assay; D003470:Culture Media; D004249:DNA Damage; D006801:Humans; D019169:Jurkat Cells; D051379:Mice; D009479:Neuropeptides / Q000096:biosynthesis / Q000235:genetics / Q000502:physiology*; D011753:Pyrones / Q000633:toxicity*; D000075370:Receptors for Activated C Kinase; D013778:Tetrazolium Salts; D013844:Thiazoles
chemical_list: D004396:Coloring Agents; D003470:Culture Media; D009479:Neuropeptides; D011753:Pyrones; C090294:RACK1 protein, mouse; D000075370:Receptors for Activated C Kinase; D013778:Tetrazolium Salts; D013844:Thiazoles; C103280:goniothalamin; C022616:thiazolyl blue
references.citation: FEBS Lett. 1999 Aug 13;456(3):379-83
references.pmid: 10462048
references.citation: J Biol Chem. 2001 Jul 20;276(29):27026-33
references.pmid: 11358958
references.citation: Leuk Res. 2009 Nov;33(11):1539-51
references.pmid: 19539371
references.citation: Cancer Immunol Immunother. 2004 Mar;53(3):160-5
references.pmid: 14722671
references.citation: Biochim Biophys Acta. 2008 Aug;1783(8):1490-502
references.pmid: 18424272
references.citation: Immunity. 1998 Apr;8(4):461-71
references.pmid: 9586636
references.citation: Chem Biol Interact. 2008 Sep 25;175(1-3):11-21
references.pmid: 18572152
references.citation: Mol Pharmacol. 2003 Dec;64(6):1541-8
references.pmid: 14645685
references.citation: Curr Med Chem. 2006;13(28):3371-84
references.pmid: 17168711
references.citation: Cell Death Differ. 2003 Sep;10(9):1016-24
references.pmid: 12934076
references.citation: Oncogene. 2001 Oct 1;20(44):6339-47
references.pmid: 11607837
references.citation: Bioorg Med Chem. 2006 Feb 1;14(3):622-31
references.pmid: 16202605
references.citation: Mol Pharmacol. 2008 Jan;73(1):119-27
references.pmid: 17911532
references.citation: Adv Enzyme Regul. 2008;48:166-78
references.pmid: 18167314
references.citation: J Leukoc Biol. 2005 Aug;78(2):503-14
references.pmid: 15870214
references.citation: J Cell Physiol. 2006 Jul;208(1):55-63
references.pmid: 16547931
references.citation: ScientificWorldJournal. 2003 Mar 17;3:51-8
references.pmid: 12806120
references.citation: Toxicol In Vitro. 2003 Aug;17(4):433-9
references.pmid: 12849726
references.citation: Oncogene. 2003 May 22;22(21):3231-42
references.pmid: 12761493
references.citation: EMBO J. 1997 Jul 1;16(13):3805-12
references.pmid: 9233790
references.citation: Chem Biol Interact. 2006 Feb 1;159(2):129-40
references.pmid: 16297902
references.citation: Oncogene. 2000 Aug 3;19(33):3774-81
references.pmid: 10949932
references.citation: Free Radic Biol Med. 2005 Jan 1;38(1):2-11
references.pmid: 15589366
references.citation: Planta Med. 1997 Feb;63(1):81-3
references.pmid: 9063100
references.citation: Eur J Pharmacol. 2005 Oct 17;522(1-3):20-9
references.pmid: 16202990
references.citation: Mutat Res. 2004 Aug 8;562(1-2):91-102
references.pmid: 15279832
references.citation: Mol Cell. 2005 Aug 5;19(3):309-20
references.pmid: 16061178
references.citation: Anticancer Res. 1998 May-Jun;18(3A):1739-43
references.pmid: 9673398
references.citation: Oncogene. 2004 Dec 16;23(58):9419-26
references.pmid: 15543234